Helgestad A, Andersen B, Njor S, Larsen M
    
    
    Heliyon. 2024; 10(13):e31163.
  
  
    PMID: 39044972
    
          PMC: 11263647.
    
          DOI: 10.1016/j.heliyon.2024.e31163.
      
 
                                  
  
    Isonne C, Marzuillo C, Villari P, Baccolini V
    
    
    Hum Vaccin Immunother. 2024; 20(1):2321675.
  
  
    PMID: 38445564
    
          PMC: 10953609.
    
          DOI: 10.1080/21645515.2024.2321675.
      
 
                                  
  
    Mills S, Donnan P, Buchanan D, Smith B
    
    
    BMC Cancer. 2023; 23(1):1174.
  
  
    PMID: 38036975
    
          PMC: 10691149.
    
          DOI: 10.1186/s12885-023-11652-1.
      
 
                                  
  
    Bolarinwa O, Holt N
    
    
    BMC Health Serv Res. 2023; 23(1):390.
  
  
    PMID: 37087506
    
          PMC: 10122823.
    
          DOI: 10.1186/s12913-023-09410-x.
      
 
                                  
  
    Flynn L, Fallows S
    
    
    Ir J Med Sci. 2023; 192(5):2085-2093.
  
  
    PMID: 36656421
    
    
          DOI: 10.1007/s11845-023-03273-1.
      
 
                              
              
                              
                                      
  Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study.
  
    Njor S, Soborg B, Tranberg M, Rebolj M
    
    
    Prev Med. 2022; 167:107405.
  
  
    PMID: 36581010
    
          PMC: 10265133.
    
          DOI: 10.1016/j.ypmed.2022.107405.
      
 
                                          
                                                          
  Barriers and Facilitators to Participation in Health Screening: an Umbrella Review Across Conditions.
  
    Le Bonniec A, Sun S, Andrin A, Dima A, Letrilliart L
    
    
    Prev Sci. 2022; 23(7):1115-1142.
  
  
    PMID: 35705780
    
    
          DOI: 10.1007/s11121-022-01388-y.
      
 
                                          
                                                          
  Increasing the uptake in a general practice prostate cancer screening programme.
  
    Limaye N, Zorzato D, Nadarajasundaram A, Ong S
    
    
    BMJ Open Qual. 2022; 11(1).
  
  
    PMID: 35272998
    
          PMC: 8915375.
    
          DOI: 10.1136/bmjoq-2021-001701.
      
 
                                          
                                                          
  Predicting the risk of cancer in adults using supervised machine learning: a scoping review.
  
    Abdullah Alfayez A, Kunz H, Grace Lai A
    
    
    BMJ Open. 2021; 11(9):e047755.
  
  
    PMID: 34521662
    
          PMC: 8442074.
    
          DOI: 10.1136/bmjopen-2020-047755.
      
 
                                          
                                                          
  A Model-Based Meta-Analysis of Willingness to Participate in Cancer Screening.
  
    Feng G, Lin Z, Ou W, Su X, Yan Q
    
    
    Int J Environ Res Public Health. 2021; 18(5).
  
  
    PMID: 33806652
    
          PMC: 7967393.
    
          DOI: 10.3390/ijerph18052580.
      
 
                                          
                                                          
  Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania.
  
    Patasius A, Krilaviciute A, Smailyte G
    
    
    J Clin Med. 2020; 9(12).
  
  
    PMID: 33255919
    
          PMC: 7760278.
    
          DOI: 10.3390/jcm9123826.
      
 
                                          
                                                          
  How narratives influence colorectal cancer screening decision making and uptake: A realist review.
  
    Woudstra A, Suurmond J
    
    
    Health Expect. 2019; 22(3):327-337.
  
  
    PMID: 31025444
    
          PMC: 6543268.
    
          DOI: 10.1111/hex.12892.
      
 
                                          
                                                          
  The association between long-term conditions and uptake of population-based screening for colorectal cancer: results from two English cohort studies.
  
    Kearns B, Chilcott J, Relton C, Whyte S, Woods H, Nickerson C
    
    
    Cancer Manag Res. 2018; 10:637-645.
  
  
    PMID: 29628776
    
          PMC: 5878662.
    
          DOI: 10.2147/CMAR.S153361.
      
 
                                          
                                                          
  Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening.
  
    Andrykowski M
    
    
    Diagnostics (Basel). 2017; 7(1).
  
  
    PMID: 28282847
    
          PMC: 5373024.
    
          DOI: 10.3390/diagnostics7010015.
      
 
                                          
                                                          
  Designing clinical and genetic guidelines of colorectal cancer screening as an effective roadmap for risk management.
  
    Zali M, Safdari R, Maserat E, Aghdaei H
    
    
    Gastroenterol Hepatol Bed Bench. 2017; 9(Suppl1):S53-S61.
  
  
    PMID: 28224029
    
          PMC: 5310801.
    
      
 
                                          
                                                          
  An empirical study of the 'underscreened' in organised cervical screening: experts focus on increasing opportunity as a way of reducing differences in screening rates.
  
    Williams J, Carter S
    
    
    BMC Med Ethics. 2016; 17(1):56.
  
  
    PMID: 27716156
    
          PMC: 5053126.
    
          DOI: 10.1186/s12910-016-0143-z.
      
 
                                          
                                                          
  Systematic screening for the detection of atrial fibrillation.
  
    Moran P, Teljeur C, Ryan M, Smith S
    
    
    Cochrane Database Syst Rev. 2016; (6):CD009586.
  
  
    PMID: 27258214
    
          PMC: 7105908.
    
          DOI: 10.1002/14651858.CD009586.pub3.
      
 
                                          
                                                          
  Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
  
    Kearns B, Whyte S, Seaman H, Snowball J, Halloran S, Butler P
    
    
    Br J Cancer. 2016; 114(3):327-33.
  
  
    PMID: 26766733
    
          PMC: 4742589.
    
          DOI: 10.1038/bjc.2015.469.
      
 
                                          
                                                          
  The role of communication in breast cancer screening: a qualitative study with Australian experts.
  
    Parker L, Rychetnik L, Carter S
    
    
    BMC Cancer. 2015; 15:741.
  
  
    PMID: 26480942
    
          PMC: 4617891.
    
          DOI: 10.1186/s12885-015-1749-0.
      
 
                                          
                                                          
  Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap?.
  
    Douglas E, Waller J, Duffy S, Wardle J
    
    
    J Med Screen. 2015; 23(2):98-103.
  
  
    PMID: 26377810
    
          PMC: 4855247.
    
          DOI: 10.1177/0969141315600192.